Fresno, California 2021-09-22 07:06:57 –
This approval is expected to cover people over the age of 65, those at high risk of serious illness, and perhaps front-line healthcare professionals.
Currently, Pfizer’s third shot is only allowed for people with weakened immunity.
If FDA approval is obtained, the CDC Advisory Board, which will meet again this week, will provide specific recommendations for boosters.
This is the day after Johnson & Johnson released new data showing that Booster Shot increased the effectiveness of the vaccine.
While a single J & J shot is more than 70% effective, the company found that the second dose was given two months after the first dose, which increased protection against symptomatic treatment to 94%.
Dr. John Brownstein, Ph.D. in Boston Children’s Hospital, said: “It’s up to the FDA to understand when and how it happens.
Last week, the FDA’s advisory board overwhelmingly rejected plans to provide Pfizer COVID-19 booster shots entirely, instead giving additional vaccines only to people over the age of 65 or at high risk of severe illness. approved.
The twin vote has hit Biden’s radical effort to strengthen the protection of almost all Americans a month ago in the epidemic of the highly contagious delta variant. rice field.
Copyright © 2021 KFSN-TV. all rights reserved.
Booster shots: FDA expected to authorize limited wider use of 3rd Pfizer vaccine Source link Booster shots: FDA expected to authorize limited wider use of 3rd Pfizer vaccine